Carbohydrates in xenotransplantation

Immunology and Cell Biology

Volumn 83, Issue 4, 2005, Pages 396-404

  Ezzelarab, Mohamed ^a   Ayares, David ^b   Cooper, David K C ^a  

^a UNIVERSITY OF PITTSBURGH MEDICAL CENTER   (United States)

^b REVIVICOR INC   (United States)

Author keywords

1,3 galactosyltransferase gene knockout; 3Gal antigen; Antipig antibodies; Carbohydrate antigen; Forssman antigen; Gal 1; Hanganutziu Deicher antigen; Oligosaccharide; Pig antigen; Xenotransplantation

Indexed keywords

ALPHA 1,3 GALACTOSYLTRANSFERASE; ANTIBODY; CARBOHYDRATE ANTIGEN; EPITOPE; FORSSMAN ANTIGEN; GALACTOSYLGALACTOSE; N GLYCOLOYLNEURAMINIC ACID;

ARTICLE; CELL NUCLEUS TRANSPLANTATION; EMBRYO TRANSFER; GRAFT REJECTION; HUMAN; HUMAN CELL; NONHUMAN; SWINE; VASCULAR ENDOTHELIUM; XENOTRANSPLANTATION;

ANIMALS; CARBOHYDRATE SEQUENCE; CARBOHYDRATES; GALACTOSE; GRAFT REJECTION; HUMANS; MOLECULAR SEQUENCE DATA; SWINE; TRANSPLANTATION, HETEROLOGOUS;

ANIMALIA; SUS SCROFA;

EID: 22944483140     PISSN: 08189641     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1440-1711.2005.01344.x     Document Type: Article

References (77)

1. Cooper DKC, Lanza RP. Xeno: The Promise of Transplanting Animal Organs into Humans. New York: Oxford University Press, 2000.
2. Appel JZ, Buhler L, Cooper DKC. The pig as a source of cardiac xenografts. J. Cardiac Surg. 2001; 16: 345-56.
3. Cooper DKC, Good AH, Koren E et al. Identification of alpha-galactosyl and other carbohydrate epitopes that are bound by human anti-pig antibodies: relevance to discordant xenografting in man. Transpl. Immunol. 1993; 1: 198-205.
4. Cooper DKC, Koren E, Oriol R. Oligosaccharides and discordant xenotransplantation. Immunol. Rev. 1994; 141: 31-58.
5. Good AH, Cooper DKC, Malcolm AJ et al. Identification of carbohydrate structures that bind human antiporcine antibodies: implications for discordant xenografting in humans. Transplant. Proc. 1992; 24: 559-62.
6. Rose AG, Cooper DKC. A histopathologic grading system of hyperacute (humoral, antibody-mediated) cardiac xenograft and allograft rejection. J. Heart Lung Transplant. 1996; 15: 804-17.
7. Wu A, Buhler LH, Cooper DKC. ABO-incompatible organ and bone marrow transplantation: current status. Transpl. Int. 2003; 16: 291-9.
8. Oriol R, Ye Y, Koren E, Cooper DKC. Carbohydrate antigens of pig tissues reacting with human natural antibodies as potential targets for hyperacute vascular rejection in pig-to-man organ xenotransplantation. Transplantation 1993; 56: 1433-42.
9. Buhler L, Yamada K, Kitamura H et al. Pig kidney transplantation in baboons: anti-Gal (alpha) 1-3Ga1 IgM alone is associated with acute humoral xenograft rejection and disseminated intravascular coagulation. Transplantation 2001; 72: 1743-52.
10. Koch CA, Khalpey ZI, Platt JL. Accommodation: preventing injury in transplantation and disease. J. Immunol. 2004; 172: 5143-8.
11. Houser SL, Kuwaki K, Knosalla C et al. Thrombotic microangiopathy and graft arteriopathy in pig hearts following transplantation into baboons. Xenotransplantation 2004; 11: 416-25.
12. Kuwaki K, Knosalla C, Dor FJ et al. Suppression of natural and elicited antibodies in pig-to-baboon heart transplantation using a human anti-human CD154 mAb-based regimen. Am. J. Transplant. 2004; 4: 363-72.
13. Kuwaki K, Tseng Y-L, Dor FJMF et al. Heart transplantation in baboons using α1,3-galactosyltransferase gene-knockout pigs as donors: initial experience. Nat. Med. 2005; 11: 29-31.
14. Eto T, Ichikawa Y, Nishimura K, Ando S, Yamakawa T. Chemistry of lipid of the posthemyolytic residue or stroma of erythrocytes. XVI. Occurrence of ceramide pentasaccharide in the membrane of erythrocytes and reticulocytes of rabbit. J. Biochem. (Tokyo) 1968; 64: 205-13.
15. Galili U, Shohet SB, Kobrin E, Stults CL, Macher BA. Man, apes, and Old World monkeys differ from other mammals in the expression of alpha-galactosyl epitopes on nucleated cells. J. Biol. Chem. 1988; 263: 17755-62.
16. Kobayashi T, Cooper DKC. Anti-Gal, alpha-Gal epitopes, and Xenotransplantation. Subcell. Biochem. 1999; 32: 229-57.
17. Spiro RG, Bhoyroo VD. Occurrence of alpha-D-galactosyl residues in the thyroglobulins from several species. Localization in the saccharide chains of the complex carbohydrate units. J. Biol. Chem. 1984; 259: 9858-66.
18. Dor FJ, Cheng J, Alt A, Cooper DKC, Schuurman HJ. Gal alpha 1,3Gal expression on porcine pancreatic islets, testis, spleen, and thymus. Xenotransplantation 2004; 11: 101-6.
19. McKenzie IF, Xing PX, Vaughan HA, Prenzoska J, Dabkowski PL, Sandrin MS. Distribution of the major xenoantigen (gal (alpha 1-3)gal) for pig to human xenografts. Transpl. Immunol. 1994; 2: 81-6.
20. Joziasse DH, Shaper JH, Jabs EW, Shaper NL. Characterization of an alpha 1,3-galactosyltransferase homologue on human chromosome 12 that is organized as a processed pseudogene. J. Biol. Chem. 1991; 266: 6991-8.
21. Larsen RD, Rivera-Marrero CA, Ernst LK, Cummings RD, Lowe JB. Frameshift and nonsense mutations in a human genomic sequence homologous to a murine UDP-Gal: beta-D-Gal(1,4)-D-GlcNAc alpha(1,3)-galactosyltransferase cDNA. J. Biol. Chem. 1990; 265: 7055-61.
22. Koren E, Neethling FA, Richards S et al. Binding and specificity of major immunoglobulin classes of preformed human anti-pig heart antibodies. Transpl. Int. 1993; 6: 351-3.
23. Kujundzic M, Koren E, Neethling FA et al. Variability of anti-αGal antibodies in human serum and their relation to serum cytotoxicity against pig cells. Xenotransplantation 1994; 1: 58-65.
24. McMorrow IM, Comrack CA, Sachs DH, DerSimonian H. Heterogeneity of human anti-pig natural antibodies cross-reactive with the Gal(alpha1,3)Galactose epitope. Transplantation 1997; 64: 501-10.
25. Roos A, Essers M, van Gijlswijk-Janssen D, Bovin NV, Daha MR. Both IgG and IgM anti-pig antibodies induce complement activation and cytotoxicity. Xenotransplantation 2001; 8: 3-14.
26. Artrip JH, Kwiatkowski P, Michler RE et al. Target cell susceptibility to lysis by human natural killer cells is augmented by alpha(1,3)- galactosyltransferase and reduced by alpha(1,2)-fucosyltransferase. J. Biol. Chem. 1999; 274: 10717-22.
27. Schaapherder AF, Daha MR, te Bulte MT, van der Woude FJ, Gooszen HG. Antibody-dependent cell-mediated cytotoxicity against porcine endothelium induced by a majority of human sera. Transplantation 1994; 57: 1376-82.
28. Alwayn IP, Xu Y, Basker M et al. Effects of specific anti-B and/or anti-plasma cell immunotherapy on antibody production in baboons: depletion of CD20- and CD22-positive B cells does not result in significantly decreased production of anti-alphaGal antibody. Xenotransplantation 2001; 8: 157-71.
29. Gojo S, Bartholomew A, Xu Y et al. Anti-Galalpha1-3Gal antibody levels in organ transplant recipients receiving immunosuppressive therapy. Transplantation 2000; 69: 914-17.
30. Buhler L, Awwad M, Basker M et al. High-dose porcine hematopoietic cell transplantation combined with CD40 ligand blockade in baboons prevents an induced anti-pig humoral response. Transplantation 2000; 69: 2296-304.
31. Galili U, LaTemple DC, Walgenbach AW, Stone KR. Porcine and bovine cartilage transplants in cynomolgus monkey: II. Changes in anti-Gal response during chronic rejection. Transplantation 1997; 63: 646-51.
32. Alwayn IP, Basker M, Buhler L, Cooper DKC. The problem of anti-pig antibodies in pig-to-primate xenografting: current and novel methods of depletion and/or suppression of production of anti-pig antibodies. Xenotransplantation 1999; 6: 157-68.
33. Romano E, Neethling FA, Nilsson K et al. Intravenous synthetic alphaGal saccharides delay hyperacute rejection following pig-to-baboon heart transplantation. Xenotransplantation 1999; 6: 36-42.
34. Simon PM, Neethling FA, Taniguchi S et al. Intravenous infusion of Galalphal-3Gal oligosaccharides in baboons delays hyperacute rejection of porcine heart xenografts. Transplantation 1998; 65: 346-53.
35. Ye Y, Neethling FA, Niekrasz M et al. Evidence that intravenously administered alpha-galactosyl carbohydrates reduce baboon serum cytotoxicity to pig kidney cells (PK15) and transplanted pig hearts. Transplantation 1994; 58: 330-7.
36. Teranishi K, Alwayn IP, Buhler L et al. Depletion of anti-Gal antibodies by the intravenous infusion of Gal type 2 and 6 glycoconjugates in baboons. Xenotransplantation 2003; 10: 57-67.
37. Koren E, Milotic F, Neethling FA et al. Murine monoclonal anti-idiotypic antibodies directed against human anti-alpha Gal antibodies prevent rejection of pig cells in culture: implications for pig-to-human organ xenotransplantation. Transplant. Proc. 1996; 28: 559.
38. Xian M, Fatima Z, Zhang W et al. Identification of alpha-galactosyl epitope mimetics through rapid generation and screening of C-linked glycopeptide library. J. Comb. Chem. 2004; 6: 126-34.
39. Kobayashi T, Taniguchi S, Neethling FA et al. Delayed xenograft rejection of pig-to-baboon cardiac transplants after cobra venom factor therapy. Transplantation 1997; 64: 1255-61.
40. Cozzi E, White DJ. The generation of transgenic pigs as potential organ donors for humans. Nat. Med. 1995; 1: 964-6.
41. Sandrin MS, Osman N, McKenzie IF. Transgenic approaches for the reduction of Galalpha(1,3)Gal for xenotransplantation. Front. Biosci. 1997; 2: e1-11.
42. Ezzelarab M, Cooper DKC. Reducing Gal expression on pig organs: a retrospective review. Xenotransplantation in press.
43. Wilmut I, Schnieke AE, McWhir J, Kind AJ, Campbell KH. Viable offspring derived from fetal and adult mammalian cells. Nature 1997; 385: 810-13.
44. Brown JP, Wei W, Sedivy JM. Bypass of senescence after disruption of p21CIP1/WAF1 gene in normal diploid human fibroblasts. Science 1997; 277: 831-4.
45. Porter AC, Itzhaki JE. Gene targeting in human somatic cells. Complete inactivation of an interferon-inducible gene. Eur. J. Biochem. 1993; 218: 273-81.
46. McCreath KJ, Howcroft J, Campbell KH, Colman A, Schnieke AE, Kind AJ. Production of gene-targeted sheep by nuclear transfer from cultured somatic cells. Nature 2000; 405: 1066-9.
47. Polejaeva IA, Chen SH, Vaught TD et al. Cloned pigs produced by nuclear transfer from adult somatic cells. Nature 2000; 407: 86-90.
48. Ayares D, Colman A, Dai Y, Shiels P, Moore M. Cloning pigs deficient in α1,3-galactosyltransferase. Graft 2001; 4: 80-2.
49. Cooper DKC, Koren E, Oriol R. Genetically engineered pigs. Lancet 1993; 342: 682-3.
50. Shinkel TA, Chen CG, Salvaris E et al. Changes in cell surface glycosylation in alpha1,3-galactosyltransferase knockout and alpha1, 2-fucosyltransferase transgenic mice. Transplantation 1997; 64: 197-204.
51. Tearle RG, Tange MJ, Zannettino ZL et al. The alpha-1,3- galactosyltransferase knockout mouse. Implications for xenotransplantation. Transplantation 1996; 61: 13-19.
52. Thall AD, Maly P, Lowe JB. Oocyte Gal alpha 1,3Gal epitopes implicated in sperm adhesion to the zona pellucida glycoprotein ZP3 are not required for fertilization in the mouse. J. Biol. Chem. 1995; 270: 21437-40.
53. Dai Y, Vaught TD, Boone J et al. Targeted disruption of the alpha1,3-galactosyltransferase gene in cloned pigs. Nat. Biotechnol. 2002; 20: 251-5.
54. Phelps CJ, Koike C, Vaught TD et al. Production of alpha 1,3-galactosyltransferase-deficient pigs. Science 2003; 299: 411-14.
55. Dor FJ, Tseng YL, Cheng J et al. alpha1,3-Galactosyltransferase gene-knockout miniature swine produce natural cytotoxic anti-Gal antibodies. Transplantation 2004; 78: 15-20.
56. Yamada K, Yazawa K, Shimizu A et al. Marked prolongation of porcine renal xenograft survival in baboons through the use of gal-T knock out donors and the co-transplantation of vascularized thymic tissue. Nat. Med. 2005; 11: 32-4.
57. Koike C, Katayama A, Kadomatsu K et al. Direct gene replacement of the mouse α(1,3) galactosyltransferase gene with human α(1,2)- fucosyltransferase gene: converting α-galactosyl epitopes into H antigens. Xenotransplantation 1997; 4: 147-53.
58. Ramsoondar JJ, Machaty Z, Costa C, Williams BL, Fodor WL, Bondioli KR. Production of alpha 1,3-galactosyltransferase-knockout cloned pigs expressing human alpha 1,2-fucosylosyltransferase. Biol. Reprod. 2003; 69: 437-45.
59. Morozumi K, Kobayashi T, Usami T et al. Significance of histochemical expression of Hanganutziu-Deicher antigens in pig, baboon and human tissues. Transplant. Proc. 1999; 31: 942-4.
60. Nowak JA, Jain NK, Stinson MW, Merrick JM. Interaction of bovine erythrocyte N-glycolylneuraminic acid-containing gangliosides and glycoproteins with a human Hanganutziu-Deicher serum. Mol. Immunol. 1986; 23: 693-700.
61. Miwa Y, Kobayashi T, Nagasaka T et al. Are N-glycolylneuraminic acid (Hanganutziu-Deicher) antigens important in pig-to-human xenotransplantation? Xenotransplantation 2004; 11: 247-53.
62. Zhu A, Hurst R. Anti-N-glycolylneuraminic acid antibodies identified in healthy human serum. Xenotransplantation 2002; 9: 376-81.
63. Bouhours D, Pourcel C, Bouhours JE. Simultaneous expression by porcine aorta endothelial cells of glycosphingolipids bearing the major epitope for human xenoreactive antibodies (Gal alpha 1-3Gal), blood group H determinant and N-glycolylneuraminic acid. Glycoconj. J. 1996; 13: 947-53.
64. Magnusson S, Mansson JE, Strokan V et al. Release of pig leukocytes during pig kidney perfusion and characterization of pig lymphocyte carbohydrate xenoantigens. Xenotransplantation 2003; 10: 432-45.
65. Komoda H, Miyagawa S, Kubo T et al. A study of the xenoantigenicity of adult pig islets cells. Xenotransplantation 2004; 11: 237-46.
66. Irie A, Suzuki A. The molecular basis for the absence of N-glycolylneuraminic acid in humans. Tanpakushitsu Kakusan Koso 1998; 43: 2404-9.
67. Kobayashi T, Yokoyama I, Suzuki A et al. Lack of antibody production against Hanganutziu-Deicher (H-D) antigens with N-glycolylneuraminic acid in patients with porcine exposure history. Xenotransplantation 2000; 7: 177-80.
68. Cooper DKC. Xenoantigens and xenoantibodies. Xenotransplantation 1998; 5: 6-17.
69. Leduc EH, Tanaka N. A study of the cellular distribution of Forssman antigen in various species. J. Immunol. 1956; 77: 198-212.
70. Yuzawa Y, Brett J, Fukatsu A et al. Interaction of antibody with Forssman antigen in guinea pigs. A mechanism of adaptation to antibody- and complement-mediated injury. Am. J. Pathol. 1995; 146: 1260-72.
71. Ono K, Hattori H, Uemura K, Nakayama J, Ota H, Katsuyama T. Expression of Forssman antigen in human large intestine. J. Histochem. Cytochem. 1994; 42: 659-65.
72. Xu H, Storch T, Yu M, Elliott SP, Haslam DB. Characterization of the human Forssman synthetase gene. An evolving association between glycolipid synthesis and host-microbial interactions. J. Biol. Chem. 1999; 274: 29390-8.
73. Levine P. Self-nonself concept for cancer and diseases previously known as 'autoimmune' diseases (illegitimate transferases/ plasma exchange). Proc. Natl. Acad. Sci. USA 1978; 75: 5697-701.
74. Schwarting GA, Kundu SK, Marcus DM. Reaction of antibodies that cause paroxysmal cold hemoglobinuria (PCH) with globoside and Forssman glycosphingolipids. Blood 1979; 53: 186-92.
75. Naiki M, Marcus DM. An immunochemical study of the human blood group P1, P, and PK glycosphingolipid antigens. Biochemistry 1915; 14: 4837-41.
76. Ariga T, Yoshida T, Mimori T, Yu RK. Autoantibodies against Forssman glycolipids in Graves' disease and Hashimoto's thyroiditis. Clin. Exp. Immunol. 1991; 86: 483-8.
77. Sandrin MS, Cohney S, Osman N, Mckenzie IFC. Overcoming the anti-Gala1-3Gal reaction to avoid hyperacute rejection: molecular genetic approaches. In: Cooper DKC, Kemp E, Platt JL, White DJG (eds). Xenotransplantation: the Transplantation of Organs and Tissues Between Species, 2nd edn. Heidelberg: Springer 1997; 683-700.